JN, G., MN, S., R, S., L, A. R., E, L., L, F., . . . TM, B. (2020). Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy. Frontiers in oncology, 10, 1381. https://doi.org/10.3389/fonc.2020.01381
Chicago Style (17th ed.) CitationJN, Graff, et al. "Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy." Frontiers in Oncology 10 (2020): 1381. https://doi.org/10.3389/fonc.2020.01381.
MLA (9th ed.) CitationJN, Graff, et al. "Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy." Frontiers in Oncology, vol. 10, 2020, p. 1381, https://doi.org/10.3389/fonc.2020.01381.